vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and UNIVERSAL TECHNICAL INSTITUTE INC (UTI). Click either name above to swap in a different company.
UNIVERSAL TECHNICAL INSTITUTE INC is the larger business by last-quarter revenue ($220.8M vs $123.8M, roughly 1.8× NATURES SUNSHINE PRODUCTS INC). UNIVERSAL TECHNICAL INSTITUTE INC runs the higher net margin — 5.8% vs 3.3%, a 2.5% gap on every dollar of revenue. On growth, UNIVERSAL TECHNICAL INSTITUTE INC posted the faster year-over-year revenue change (9.6% vs 4.7%). NATURES SUNSHINE PRODUCTS INC produced more free cash flow last quarter ($7.6M vs $-19.2M). Over the past eight quarters, UNIVERSAL TECHNICAL INSTITUTE INC's revenue compounded faster (9.5% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
Universal Technical Institute, Inc. (UTI) is a private for-profit system of technical colleges in the United States. It was established in 1965 by Robert Sweet.
NATR vs UTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $220.8M |
| Net Profit | $4.1M | $12.8M |
| Gross Margin | 72.5% | — |
| Operating Margin | 4.3% | 7.1% |
| Net Margin | 3.3% | 5.8% |
| Revenue YoY | 4.7% | 9.6% |
| Net Profit YoY | 1379.4% | -42.1% |
| EPS (diluted) | $0.23 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $220.8M | ||
| Q3 25 | $128.3M | $222.4M | ||
| Q2 25 | $114.8M | $204.3M | ||
| Q1 25 | $113.2M | $207.4M | ||
| Q4 24 | $118.2M | $201.4M | ||
| Q3 24 | $114.6M | $196.4M | ||
| Q2 24 | $110.6M | $177.5M | ||
| Q1 24 | $111.0M | $184.2M |
| Q4 25 | $4.1M | $12.8M | ||
| Q3 25 | $5.3M | $18.8M | ||
| Q2 25 | $5.3M | $10.7M | ||
| Q1 25 | $4.7M | $11.4M | ||
| Q4 24 | $-321.0K | $22.2M | ||
| Q3 24 | $4.3M | $18.8M | ||
| Q2 24 | $1.3M | $5.0M | ||
| Q1 24 | $2.3M | $7.8M |
| Q4 25 | 72.5% | — | ||
| Q3 25 | 73.3% | — | ||
| Q2 25 | 71.7% | — | ||
| Q1 25 | 72.1% | — | ||
| Q4 24 | 72.0% | — | ||
| Q3 24 | 71.3% | — | ||
| Q2 24 | 71.4% | — | ||
| Q1 24 | 71.2% | — |
| Q4 25 | 4.3% | 7.1% | ||
| Q3 25 | 7.0% | 11.2% | ||
| Q2 25 | 3.7% | 6.9% | ||
| Q1 25 | 5.4% | 8.1% | ||
| Q4 24 | 3.8% | 13.6% | ||
| Q3 24 | 4.6% | 13.3% | ||
| Q2 24 | 5.1% | 4.2% | ||
| Q1 24 | 4.2% | 6.1% |
| Q4 25 | 3.3% | 5.8% | ||
| Q3 25 | 4.2% | 8.4% | ||
| Q2 25 | 4.6% | 5.2% | ||
| Q1 25 | 4.2% | 5.5% | ||
| Q4 24 | -0.3% | 11.0% | ||
| Q3 24 | 3.8% | 9.6% | ||
| Q2 24 | 1.2% | 2.8% | ||
| Q1 24 | 2.1% | 4.2% |
| Q4 25 | $0.23 | $0.23 | ||
| Q3 25 | $0.30 | $0.33 | ||
| Q2 25 | $0.28 | $0.19 | ||
| Q1 25 | $0.25 | $0.21 | ||
| Q4 24 | $-0.02 | $0.40 | ||
| Q3 24 | $0.23 | $0.35 | ||
| Q2 24 | $0.07 | $0.09 | ||
| Q1 24 | $0.12 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $162.8M |
| Total DebtLower is stronger | — | $101.4M |
| Stockholders' EquityBook value | $161.6M | $335.9M |
| Total Assets | $261.1M | $834.0M |
| Debt / EquityLower = less leverage | — | 0.30× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $162.8M | ||
| Q3 25 | $95.6M | $169.1M | ||
| Q2 25 | $81.3M | $70.7M | ||
| Q1 25 | $86.5M | $96.0M | ||
| Q4 24 | $84.7M | $172.0M | ||
| Q3 24 | $78.7M | $161.9M | ||
| Q2 24 | $68.7M | $115.5M | ||
| Q1 24 | $77.8M | $116.1M |
| Q4 25 | — | $101.4M | ||
| Q3 25 | — | $87.1M | ||
| Q2 25 | — | $73.8M | ||
| Q1 25 | — | $94.4M | ||
| Q4 24 | — | $120.1M | ||
| Q3 24 | — | $125.7M | ||
| Q2 24 | — | $137.3M | ||
| Q1 24 | $2.1M | $141.9M |
| Q4 25 | $161.6M | $335.9M | ||
| Q3 25 | $166.7M | $328.1M | ||
| Q2 25 | $163.7M | $306.8M | ||
| Q1 25 | $167.1M | $293.9M | ||
| Q4 24 | $161.0M | $280.0M | ||
| Q3 24 | $162.6M | $260.2M | ||
| Q2 24 | $156.4M | $239.4M | ||
| Q1 24 | $159.7M | $232.6M |
| Q4 25 | $261.1M | $834.0M | ||
| Q3 25 | $264.8M | $826.1M | ||
| Q2 25 | $254.9M | $740.8M | ||
| Q1 25 | $252.7M | $720.4M | ||
| Q4 24 | $240.9M | $753.8M | ||
| Q3 24 | $245.3M | $744.6M | ||
| Q2 24 | $235.8M | $706.0M | ||
| Q1 24 | $247.3M | $702.1M |
| Q4 25 | — | 0.30× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.32× | ||
| Q4 24 | — | 0.43× | ||
| Q3 24 | — | 0.48× | ||
| Q2 24 | — | 0.57× | ||
| Q1 24 | 0.01× | 0.61× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $3.1M |
| Free Cash FlowOCF − Capex | $7.6M | $-19.2M |
| FCF MarginFCF / Revenue | 6.1% | -8.7% |
| Capex IntensityCapex / Revenue | 1.9% | 10.1% |
| Cash ConversionOCF / Net Profit | 2.41× | 0.24× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $16.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $3.1M | ||
| Q3 25 | $18.5M | $57.1M | ||
| Q2 25 | $4.3M | $18.1M | ||
| Q1 25 | $2.6M | $-789.0K | ||
| Q4 24 | $12.2M | $23.0M | ||
| Q3 24 | $9.6M | $67.5M | ||
| Q2 24 | $1.3M | $10.0M | ||
| Q1 24 | $2.2M | $-2.5M |
| Q4 25 | $7.6M | $-19.2M | ||
| Q3 25 | $16.8M | $40.6M | ||
| Q2 25 | $3.0M | $6.8M | ||
| Q1 25 | $1.5M | $-11.7M | ||
| Q4 24 | $10.0M | $19.6M | ||
| Q3 24 | $7.9M | $60.0M | ||
| Q2 24 | $-2.0M | $3.0M | ||
| Q1 24 | $-1.5M | $-8.4M |
| Q4 25 | 6.1% | -8.7% | ||
| Q3 25 | 13.1% | 18.3% | ||
| Q2 25 | 2.6% | 3.4% | ||
| Q1 25 | 1.3% | -5.7% | ||
| Q4 24 | 8.5% | 9.7% | ||
| Q3 24 | 6.9% | 30.6% | ||
| Q2 24 | -1.9% | 1.7% | ||
| Q1 24 | -1.4% | -4.6% |
| Q4 25 | 1.9% | 10.1% | ||
| Q3 25 | 1.3% | 7.4% | ||
| Q2 25 | 1.2% | 5.5% | ||
| Q1 25 | 1.0% | 5.3% | ||
| Q4 24 | 1.9% | 1.7% | ||
| Q3 24 | 1.5% | 3.8% | ||
| Q2 24 | 3.0% | 4.0% | ||
| Q1 24 | 3.3% | 3.2% |
| Q4 25 | 2.41× | 0.24× | ||
| Q3 25 | 3.46× | 3.04× | ||
| Q2 25 | 0.81× | 1.69× | ||
| Q1 25 | 0.55× | -0.07× | ||
| Q4 24 | — | 1.04× | ||
| Q3 24 | 2.21× | 3.58× | ||
| Q2 24 | 0.97× | 2.01× | ||
| Q1 24 | 0.94× | -0.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
UTI
| UTI | $142.8M | 65% |
| Concorde | $78.0M | 35% |
